The purpose of this study is to learn the effects of two mild body exercises on quality of life, non-motor symptoms, anxiety, depression, fatigue, sleep quality, cognition, and executive function on people with Parkinson's Disease (PD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
65
The Qigong exercise is a series of mild exercise movements.
Participants will be taught of series of similar movements to the Qigong exercise.
University of Kansas Medical Center
Kansas City, Kansas, United States
Parkinson's Disease Sleep Scale (PDSS-2)
This instrument has a total range of scores between 0 and 60. The lower the score the better.
Time frame: Change from Baseline to Week 12
Parkinson's Disease Questionnaire (PDQ-39)
Measure of quality of life. This instrument has a total range of scores between 0 and 156. The lower the score the better.
Time frame: Change from Baseline to Week 12
Non Motor Symptom Questionnaire (NMSQuest)
This instrument has a total range of scores between 0 and 30. The lower the score the better.
Time frame: Change from Baseline to Week 12
Geriatric Anxiety Scale (GAS-10)
This instrument has a total range of scores between 0 and 30. The lower the score the better.
Time frame: Change from Baseline to Week 12
Geriatric Depression Scale (GDS-15)
This instrument has a total range of scores between 0 and 15. The lower the score the better.
Time frame: Change from Baseline to Week 12
Parkinson Fatigue Scale (PFS-16)
This instrument has a total range of scores between 16 and 90. The lower the score the better.
Time frame: Change from Baseline to Week 12
Parkinson's Disease-Cognitive Rating Scale (PD-CRS)
This instrument has a total range of scores between 0 and 134. The higher the score the better.
Time frame: Change from Baseline to Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Frontal Assessment Battery (FAB-18)
This instrument has a total range of scores between 0 and 18. The higher the score the better.
Time frame: Change from Baseline to Week 12
Trail Making Test parts A
This test examines the time required to complete a task of connecting numbers in ascending sequence.
Time frame: Change from Baseline to Week 12
Trail Making Test parts B
This test examines the required time for completing a task of connecting numbers and letters in ascending sequence.
Time frame: Change from Baseline to Week 12
Unified Parkinson Disease Rating Scale (UPDRS)
This instrument has a total range of scores between 0 and 199. The lower the score the better.
Time frame: Change from Baseline to Week 12
IL-1beta
Serum biomarker will be measured by Enzyme Linked Immuno-Sorbent Assay (ELISA).
Time frame: Change from Baseline to Week 12
IL-6
Serum biomarker will be measured by Enzyme Linked Immuno-Sorbent Assay (ELISA).
Time frame: Change from Baseline to Week 12
TNF-alpha
Serum biomarker will be measured by Enzyme Linked Immuno-Sorbent Assay (ELISA).
Time frame: Change from Baseline to Week 12